- Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue Jul 29, 2019 FOR IMMEDIATE RELEASE July 25, 2019 CONTACTS: Jack Mozloom, National Community Pharmacists Association Chris Krese, National... read more
- 105 U.S. Reps., 28 U.S. Senators Urge Trump Administration to Fix Pharmacy DIR Fees Jun 20, 2019 FOR IMMEDIATE RELEASE June 20, 2019 CONTACTS: Jack Mozloom, National Community Pharmacists Association Chris Krese,... read more
- Pharmacy United in Call for President Trump to Act on DIR Fee Reform Jun 10, 2019 FOR IMMEDIATE RELEASEJune 10, 2019 CONTACTS: Jack Mozloom, National Community Pharmacists AssociationChris Krese, National Association of... read more
- Final Medicare Drug Pricing Rule Fails to Lower Prices at the Pharmacy Counter May 17, 2019 For Immediate Release May 17, 2019 Contact: Sheila Arquette, Executive Director, (703) 842-0122 WASHINGTON, DC –... read more
- NASP’s Comments on the Office of Inspector General (OIG) Department of Health and Human Services (HHS) proposed regulation Apr 09, 2019 The National Association of Specialty Pharmacy (NASP) is pleased to represent the entire spectrum of the... read more
- NASP’s Comments on the Centers for Medicare and Medicaid Services’ (CMS) proposed regulation Jan 25, 2019 The National Association of Specialty Pharmacy (NASP) is pleased to represent the entire spectrum of the... read more
- Final Medicare Part D Rule and CY 2019 Call letter released Apr 03, 2018 CMS issued a final Medicare Part D Rule and Part D Call Letter for CY 2019... read more
- Health care groups calling on lawmakers to pass a Medicare package to restore funding for expired Medicare programs Feb 05, 2018 The National Association of Specialty Pharmacy offered its support of a letter sent to congressional leaders... read more
- NASP submits comments to CMS on Medicare Proposed Rule for Contract Year 2019 Jan 17, 2018 NASP represents an industry that focuses on providing high quality patient care first with additional emphasis... read more
- NASP’s comments to FTC’s Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics Workshop Dec 12, 2017 NASP represents an industry that focuses on providing high quality patient care first with an added... read more